Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

APOBEC3 inhibition of mouse mammary tumor virus infection: the role of cytidine deamination versus inhibition of reverse transcription.

MacMillan AL, Kohli RM, Ross SR.

J Virol. 2013 May;87(9):4808-17. doi: 10.1128/JVI.00112-13. Epub 2013 Feb 28.

2.

APOBEC3 proteins expressed in mammary epithelial cells are packaged into retroviruses and can restrict transmission of milk-borne virions.

Okeoma CM, Huegel AL, Lingappa J, Feldman MD, Ross SR.

Cell Host Microbe. 2010 Dec 16;8(6):534-43. doi: 10.1016/j.chom.2010.11.003.

3.

Expression of murine APOBEC3 alleles in different mouse strains and their effect on mouse mammary tumor virus infection.

Okeoma CM, Petersen J, Ross SR.

J Virol. 2009 Apr;83(7):3029-38. doi: 10.1128/JVI.02536-08. Epub 2009 Jan 19.

4.

Incorporation of mouse APOBEC3 into murine leukemia virus virions decreases the activity and fidelity of reverse transcriptase.

Boi S, Kolokithas A, Shepard J, Linwood R, Rosenke K, Van Dis E, Malik F, Evans LH.

J Virol. 2014 Jul;88(13):7659-62. doi: 10.1128/JVI.00967-14. Epub 2014 Apr 9.

5.
6.

Induction of APOBEC3 in vivo causes increased restriction of retrovirus infection.

Okeoma CM, Low A, Bailis W, Fan HY, Peterlin BM, Ross SR.

J Virol. 2009 Apr;83(8):3486-95. doi: 10.1128/JVI.02347-08. Epub 2009 Jan 19.

7.

Murine leukemia virus glycosylated Gag blocks apolipoprotein B editing complex 3 and cytosolic sensor access to the reverse transcription complex.

Stavrou S, Nitta T, Kotla S, Ha D, Nagashima K, Rein AR, Fan H, Ross SR.

Proc Natl Acad Sci U S A. 2013 May 28;110(22):9078-83. doi: 10.1073/pnas.1217399110. Epub 2013 May 13.

8.

Suppression of HIV-1 infection by APOBEC3 proteins in primary human CD4(+) T cells is associated with inhibition of processive reverse transcription as well as excessive cytidine deamination.

Gillick K, Pollpeter D, Phalora P, Kim EY, Wolinsky SM, Malim MH.

J Virol. 2013 Feb;87(3):1508-17. doi: 10.1128/JVI.02587-12. Epub 2012 Nov 14.

9.

Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo.

Barrett BS, Guo K, Harper MS, Li SX, Heilman KJ, Davidson NO, Santiago ML.

Virology. 2014 Nov;468-470:601-8. doi: 10.1016/j.virol.2014.09.006. Epub 2014 Oct 7.

10.

Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo.

Takeda E, Tsuji-Kawahara S, Sakamoto M, Langlois MA, Neuberger MS, Rada C, Miyazawa M.

J Virol. 2008 Nov;82(22):10998-1008. doi: 10.1128/JVI.01311-08. Epub 2008 Sep 10.

11.

Moderate sensitivity of mouse mammary tumour virus to inhibition by human APOBEC3G.

Konstantoulas CJ, Hagen B, Indik S.

J Gen Virol. 2017 Sep;98(9):2362-2367. doi: 10.1099/jgv.0.000897. Epub 2017 Aug 18.

PMID:
28809145
12.

Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo.

Santiago ML, Benitez RL, Montano M, Hasenkrug KJ, Greene WC.

J Immunol. 2010 Jul 15;185(2):1114-23. doi: 10.4049/jimmunol.1001143. Epub 2010 Jun 21.

13.

The AKV murine leukemia virus is restricted and hypermutated by mouse APOBEC3.

Langlois MA, Kemmerich K, Rada C, Neuberger MS.

J Virol. 2009 Nov;83(22):11550-9. doi: 10.1128/JVI.01430-09. Epub 2009 Sep 2.

14.
15.

RIII/Sa mice with a high incidence of mammary tumors express two exogenous strains and one potential endogenous strain of mouse mammary tumor virus.

Sarkar NH, Golovkina T, Uz-Zaman T.

J Virol. 2004 Jan;78(2):1055-62. Erratum in: J Virol. 2004 Apr;78(7):3803.

16.

APOBEC3 inhibits mouse mammary tumour virus replication in vivo.

Okeoma CM, Lovsin N, Peterlin BM, Ross SR.

Nature. 2007 Feb 22;445(7130):927-30. Epub 2007 Jan 28.

PMID:
17259974
17.

Biochemical and biological studies of mouse APOBEC3.

Nair S, Sanchez-Martinez S, Ji X, Rein A.

J Virol. 2014 Apr;88(7):3850-60. doi: 10.1128/JVI.03456-13. Epub 2014 Jan 22.

18.

Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection.

Santiago ML, Montano M, Benitez R, Messer RJ, Yonemoto W, Chesebro B, Hasenkrug KJ, Greene WC.

Science. 2008 Sep 5;321(5894):1343-6. doi: 10.1126/science.1161121.

19.

Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response.

Smith DS, Guo K, Barrett BS, Heilman KJ, Evans LH, Hasenkrug KJ, Greene WC, Santiago ML.

PLoS Pathog. 2011 Oct;7(10):e1002284. doi: 10.1371/journal.ppat.1002284. Epub 2011 Oct 6.

20.

Supplemental Content

Support Center